Politics & policy

Insight into federal and state health care legislation & CMS regulation

FDA To Regulate Drug Company-Owned PBMs

The Food and Drug Administration issued a draft guideline last month that would hold drug manufacturers liable for the activities of pharmacy benefit managers they own. The FDA wants PBMs to adhere to the same truth-in-advertising rules pharmaceutical companies must observe. The idea is to prevent PBMs from making misleading product claims.

PBMs would have to submit promotional materials to the FDA for approval, as drug makers already do. "Pharmaceutical manufacturers should not be permitted to avoid regulation by changing the form through which their communications are accomplished," an FDA official said. The comment period ends April 6.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

2018 Year in Preview
By Susan Ladika
2018 Year in Preview
By Thomas Reinke